Long-Term Therapy With Ribavirin for Chronic Hepatitis C

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 12, 1999

Primary Completion Date

October 10, 2007

Study Completion Date

January 15, 2008

Conditions
Chronic Hepatitis C
Interventions
DRUG

Ribavirin

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00001854 - Long-Term Therapy With Ribavirin for Chronic Hepatitis C | Biotech Hunter | Biotech Hunter